Extraintestinal manifestations of inflammatory bowel disease

被引:69
|
作者
Williams H. [1 ]
Walker D. [1 ]
Orchard T.R. [1 ]
机构
[1] Imperial College London, St. Mary's Hospital, GI Unit, London W2 1NY, Praed Street
关键词
Ulcerative Colitis; Ankylose Spondylitis; Primary Sclerosing Cholangitis; Mesalazine; Pyoderma Gangrenosum;
D O I
10.1007/s11894-008-0108-6
中图分类号
学科分类号
摘要
The idiopathic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, may be complicated by extraintestinal manifestations (EIMs) in up to 40% of patients. Reports suggest that almost every organ system may be affected. The EIMs are a significant cause of morbidity and may be particularly distressing for the patient. Recent attempts have been made to define the phenotype of IBD in patients of different ethnicities. These studies have highlighted potential racial variations in the prevalence of specific EIMs, findings that are perhaps not surprising given the influence of genetic factors in their pathogenesis. Certain EIMs are related to the activity of the bowel disease, and their management often involves careful monitoring while the IBD is brought under control. Other EIMs, however, typically run a course independent of the IBD activity, and specific, targeted treatments may be required, even including biologic agents such as infliximab. © Springer Science+Business Media, LLC 2008.
引用
收藏
页码:597 / 605
页数:8
相关论文
共 50 条
  • [41] Update in the management of extraintestinal manifestations of inflammatory bowel disease
    Patil S.A.
    Cross R.K.
    Current Gastroenterology Reports, 2013, 15 (3)
  • [42] Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fedor, Istvan
    Zold, Eva
    Barta, Zsolt
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (24)
  • [43] Extraintestinal manifestations of inflammatory bowel diseases
    Kethu, Sripathi R.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (06) : 467 - 475
  • [44] PREDICTORS OF DEVELOPING MULTIPLE EXTRAINTESTINAL MANIFESTATIONS OF INFLAMMATORY BOWEL DISEASE
    Alizadeh, Madeline
    Motwani, Kiran
    Cross, Raymond
    GASTROENTEROLOGY, 2023, 164 (04) : S36 - S37
  • [45] Comprehensive Association Analyses of Extraintestinal Manifestations in Inflammatory Bowel Disease
    Khrom, Michelle
    Long, Millie
    Dube, Shishir
    Robbins, Lori
    Botwin, Gregory J.
    Yang, Shaohong
    Mengesha, Emebet
    Li, Dalin
    Naito, Takeo
    Bonthala, Nirupama N.
    Ha, Christina
    Melmed, Gil
    Rabizadeh, Shervin
    Syal, Gaurav
    Vasiliauskas, Eric
    Ziring, David
    Brant, Steven R.
    Cho, Judy
    Duerr, Richard H.
    Rioux, John
    Schumm, Phil
    Silverberg, Mark
    Ananthakrishnan, Ashwin N.
    Faubion, William A.
    Jabri, Bana
    Lira, Sergio A.
    Newberry, Rodney D.
    Sandler, Robert S.
    Xavier, Ramnik J.
    Kugathasan, Subra
    Hercules, David
    Targan, Stephan R.
    Sartor, R. Balfour
    Haritunians, Talin
    Mcgovern, Dermot P. B.
    GASTROENTEROLOGY, 2024, 167 (02) : 315 - 332
  • [46] Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management
    Garber A.
    Regueiro M.
    Current Gastroenterology Reports, 2019, 21 (7)
  • [47] Extraintestinal manifestations of pediatric inflammatory bowel disease in Saudi Arabia
    Al-Mendalawi, Mahmood D.
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2018, 24 (05): : 307 - 307
  • [48] Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
    Fleisher, Mark
    Marsal, Jan
    Lee, Scott D.
    Frado, Laura E.
    Parian, Alyssa
    Korelitz, Burton I.
    Feagan, Brian G.
    DIGESTIVE DISEASES AND SCIENCES, 2018, 63 (04) : 825 - 833
  • [49] Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review
    Wang, Yuanzhuo
    Wan, Ziqi
    Jin, Rui
    Xu, Tianming
    Ouyang, Yan
    Wang, Baihui
    Ruan, Gechong
    Bai, Xiaoyin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 105
  • [50] Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease
    Hertz, Sandra
    Anderson, Jacqueline Moltzau
    Nielsen, Hans Linde
    Schachtschneider, Claire
    McCauley, Kathryn E.
    Ozcam, Mustafa
    Larsen, Lone
    Lynch, Susan V.
    Nielsen, Henrik
    ANNALS OF MEDICINE, 2024, 56 (01)